<DOC>
	<DOCNO>NCT01575899</DOCNO>
	<brief_summary>This prospective control randomized open-label clinical trial design determine eradication rate 7-day levofloxacin , amoxicillin/clavulanate rabeprazole regimen compare 7-day standard triple therapy adult infect Helicobacter pylori Eastern Taiwan .</brief_summary>
	<brief_title>Efficacy Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin Eradication Helicobacter Pylori</brief_title>
	<detailed_description>BACKGROUND : The resistance rate Helicobacter pylorus ( Hp ) amoxicillin metronidazole therapy significantly high Eastern Taiwan compare national worldwide rate . The high resistance rate territory justify search well eradication regimen Hp infection . AIM : To evaluate efficacy tolerability combination therapeutic regimen levofloxacin , amoxicillin/clavulanate rabeprazole ( LAcR ) versus conventional seven-day triple therapy clarithromycin , amoxicillin rabeprazole ( CAR ) eradication Hp infection . METHODS : We conduct open-labeled , prospective , randomize , control study large tertiary referral hospital Eastern Taiwan . Hp-positive therapy-na√Øve patient positive CLO test proven gastroscopy recruit potential random assignment two 7-day treatment group : LAcR CAR ( control ) . The primary end point study evaluate eradication rate LAcR regimen . Hp eradication assess use 13C-urea breath test CLO test perform least 4 week end treatment . Compliance adverse effect therapy determine phone call outpatient clinic follow . EXPECTED RESULT : The seven-day LAcR regimen evaluate study provide improved Hp eradication efficacy compare traditional seven-day triple therapy Eastern Taiwan .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Patient prove infection H. pylori gastric mucosa Patient sign informed consent . woman breast feeding pregnancy . allergy severe adverse effect drug use study . severe complication peptic ulcer disease ( like perforation obstruction ) . patient history cancer failure major organ .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Levofloxacin</keyword>
	<keyword>Amoxicillin/clavulanate</keyword>
	<keyword>Rabeprazole</keyword>
	<keyword>Eastern Taiwan</keyword>
</DOC>